Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Status of head and neck brachytherapy in Spain in 2022.
Guinot JL, Diezhandino P, de Frutos JM, Fuentemilla N, Gonzalez-Perez V, Gutierrez C, Herreros A, Martinez-Monge R, Perez-Echagüen S, Pino F, Roldán S, Rovirosa A, Santos MA, Sanz-Freire CJ, Villafranca E. Guinot JL, et al. Among authors: diezhandino p. Clin Transl Oncol. 2024 Feb;26(2):456-460. doi: 10.1007/s12094-023-03265-8. Epub 2023 Aug 7. Clin Transl Oncol. 2024. PMID: 37548869
Treatment planning considerations for 125I eye plaque brachytherapy.
Miguel D, de Frutos JM, López-Lara F, Alonso P, Diezhandino P, Saornil MA, García C. Miguel D, et al. Among authors: diezhandino p. J Contemp Brachytherapy. 2019 Jun;11(3):280-284. doi: 10.5114/jcb.2019.86370. Epub 2019 Jun 28. J Contemp Brachytherapy. 2019. PMID: 31435435 Free PMC article.
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR).
Valero J, Peleteiro P, Henríquez I, Conde A, Piquer T, Lozano A, Soler CC, Muñoz J, Illescas A, Jove J, Flores MM, Baquedano J, Diezhandino P, de Celis RP, Pardo EH, Samper P, Villoslada I, Eguiguren M, Millan V. Valero J, et al. Among authors: diezhandino p. Clin Transl Oncol. 2020 Aug;22(8):1378-1389. doi: 10.1007/s12094-019-02274-w. Epub 2020 Jan 27. Clin Transl Oncol. 2020. PMID: 31989474
Brachytherapy in the prevention of recurrence of conjunctival melanoma : Results of a case report in a University Hospital in Valladolid, Spain.
Pacheco-Callirgos GE, García-Alvarez C, Garcia-Onrubia L, Miguel-Pérez D, Alonso-Martinez P, Diezhandino P, de Frutos Barajas JM, Saornil-Alvarez MA. Pacheco-Callirgos GE, et al. Among authors: diezhandino p. Strahlenther Onkol. 2023 Nov;199(11):1025-1030. doi: 10.1007/s00066-023-02094-6. Epub 2023 Jun 6. Strahlenther Onkol. 2023. PMID: 37280383
Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II.
Miguel D, de Frutos-Baraja JM, López-Lara F, Saornil MA, García-Álvarez C, Alonso P, Diezhandino P. Miguel D, et al. Among authors: diezhandino p. J Contemp Brachytherapy. 2018 Aug;10(4):347-359. doi: 10.5114/jcb.2018.77955. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237818 Free PMC article.
Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I.
Miguel D, de Frutos-Baraja JM, López-Lara F, Saornil MA, García-Álvarez C, Alonso P, Diezhandino P. Miguel D, et al. Among authors: diezhandino p. J Contemp Brachytherapy. 2018 Aug;10(4):337-346. doi: 10.5114/jcb.2018.77849. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237817 Free PMC article.
13 results